• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Characterization of immuno-suppressive NKT cells in mouse pancreatic cancer model

Research Project

Project/Area Number 16K21269
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Immunology
Gastroenterology
Research InstitutionYokohama City University

Principal Investigator

KATO Shingo  横浜市立大学, 附属病院, 助教 (20622583)

Project Period (FY) 2016-04-01 – 2018-03-31
Project Status Completed (Fiscal Year 2017)
Budget Amount *help
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2017: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2016: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
KeywordsNatural Killer T 細胞 / 膵癌 / NKT細胞 / 腫瘍免疫学 / Natural Killer T細胞
Outline of Final Research Achievements

Functional analysis of tumor immunosuppressive Natural Killer T (NKT) cells in pancreatic cancer mouse model was performed. NKT cells are unique T cell subset that recognizes lipid antigens and bridge the innate immune system and the acquired immune system. There are two subsets of NKT cells, type I NKT cells that enhance tumor immunity and type II NKT cells that suppress tumor immunity. Analysis was carried out using mouse pancreatic cancer cell line orthotopic transplant model and knockout mouse of NKT cell. As a result, proliferation of pancreatic cancer cell line was promoted in knockout mice of NKT cells, suggesting that NKT cells may be involved in antitumor immunity. From now on, we analyze the detailed mechanism of this phenomenon.

Report

(3 results)
  • 2017 Annual Research Report   Final Research Report ( PDF )
  • 2016 Research-status Report
  • Research Products

    (5 results)

All 2018 2017 2016

All Journal Article (2 results) (of which Int'l Joint Research: 2 results,  Peer Reviewed: 2 results,  Open Access: 2 results) Presentation (3 results)

  • [Journal Article] Possible Therapeutic Application of Targeting Type II Natural Killer T Cell-Mediated Suppression of Tumor Immunity.2018

    • Author(s)
      Kato S, Berzofsky JA, Terabe M
    • Journal Title

      Frontiers in immunology

      Volume: 9 Pages: 314-314

    • DOI

      10.3389/fimmu.2018.00314

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Blockade of only TGF-β 1 and 2 is sufficient to enhance the efficacy of vaccine and PD-1 checkpoint blockade immunotherapy.2017

    • Author(s)
      Terabe M, Robertson FC, Clark K, De Ravin E, Bloom A, Venzon DJ, Kato S, Mirza A, Berzofsky JA
    • Journal Title

      OncoImmunology

      Volume: 6 Issue: 5 Pages: e1308616-e1308616

    • DOI

      10.1080/2162402x.2017.1308616

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Presentation] Characterization of type II NKT cells in mouse lungs using sulfatide-loaded CD1d tetramers2016

    • Author(s)
      Shingo Kato
    • Organizer
      第45回日本免疫学会学術集会
    • Place of Presentation
      沖縄コンベンションセンター(沖縄県)
    • Year and Date
      2016-12-05
    • Related Report
      2016 Research-status Report
  • [Presentation] Characterization of immuno-suppressive NKT cells in mouse lungs2016

    • Author(s)
      Shingo Kato
    • Organizer
      第75回 日本癌学会総会
    • Place of Presentation
      パシフィコ横浜(神奈川県)
    • Year and Date
      2016-10-06
    • Related Report
      2016 Research-status Report
  • [Presentation] Characterization of sulfatide reactive type II NKT cells in mouse lungs2016

    • Author(s)
      Shingo Kato
    • Organizer
      第20回 日本がん免疫学会総会
    • Place of Presentation
      大阪国際交流センター(大阪府)
    • Year and Date
      2016-07-27
    • Related Report
      2016 Research-status Report

URL: 

Published: 2016-04-21   Modified: 2019-03-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi